Brought to you by 
Merck KGAA and Domain partner again, this time in immuno-oncology
29 Oct 2021
Executive Summary
A few years after their first collaboration was terminated, Merck KGAA and Domain Therapeutics SA are teaming up again, this time to develop new immuno-oncology therapeutics.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Immuno-Oncology
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement